Jeong Dong Seop, Kim Wook Sung, Sung Kiick, Yang Ji-Hyuk, Jun Tae-Gook, Lee Young Tak, Park Pyo Won
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Heart Valve Dis. 2013 Nov;22(6):794-803.
The study aim was to evaluate the long-term hemodynamic performance of ATS bileaflet valves in the aortic position.
A total of 132 patients (mean age 54 +/- 13 years) who underwent aortic valve replacement (AVR) using ATS valves between October 1994 and May 2001 was analyzed. Of these patients, 77 underwent isolated AVR (AVR group), while 55 underwent concomitant mitral valve replacement (DVR group). The mean follow up duration was 135 +/- 39 months (maximum 180 months).
The overall mortality was 19.7% (26/132), but no early mortality occurred. Cumulative survival rates at 12 years were 87.0 +/- 3.8% in the AVR group and 71.4 +/- 6.3% in the DVR group (p = 0.093). The AVR group showed a higher cardiovascular event-free survival at 12 years than the DVR group (82.3 +/- 4.7% versus 65.1 +/- 7.3%; p = 0.047). During follow up, the transaortic mean pressure gradient (TMPG) was maintained in the AVR group but increased in the DVR group (p = 0.044). The TMPG at follow up was higher in patients who underwent AVR with small valves (< or =21 mm) than in those receiving large valves (p = 0.001). The tricuspid regurgitation (TR) grade was increased over time in both groups, and was greater in the DVR group (2.1 +/- 1.1 versus 1.4 +/- 1.0; p < 0.001). The progression of late TR correlated with the TMPG (gamma = 0.261, p = 0.022).
The study results showed that ATS valves had acceptable long-term outcomes. A high TMPG was observed more frequently in the DVR group and in patients who underwent AVR with a small valve. A high TMPG might be related to the progression of late TR.
本研究旨在评估主动脉位ATS双叶瓣的长期血流动力学性能。
分析了1994年10月至2001年5月期间共132例使用ATS瓣膜进行主动脉瓣置换术(AVR)的患者(平均年龄54±13岁)。其中,77例接受单纯AVR(AVR组),55例接受同期二尖瓣置换术(DVR组)。平均随访时间为135±39个月(最长180个月)。
总死亡率为19.7%(26/132),但无早期死亡病例。AVR组12年累积生存率为87.0±3.8%,DVR组为71.4±6.3%(p = 0.093)。AVR组12年无心血管事件生存率高于DVR组(82.3±4.7%对65.1±7.3%;p = 0.047)。随访期间,AVR组经主动脉平均压力阶差(TMPG)保持稳定,而DVR组升高(p = 0.044)。接受小瓣膜(≤21 mm)AVR的患者随访时的TMPG高于接受大瓣膜患者(p = 0.001)。两组三尖瓣反流(TR)分级均随时间增加,且DVR组更高(2.1±1.1对1.4±1.0;p < 0.001)。晚期TR的进展与TMPG相关(γ = 0.261,p = 0.022)。
研究结果表明,ATS瓣膜具有可接受的长期预后。DVR组以及接受小瓣膜AVR的患者更常观察到高TMPG。高TMPG可能与晚期TR的进展有关。